Background. To analyze the immune phenotype of Tlymphocyte infiltrations in surveillance renal biopsies with stable renal function early post-transplantation (median time 40 days, range from 18 to 85 days). Methods. One hundred and twenty-five surveillance biopsies with interstitial T-lymphocyte infiltration between non-atrophic tubules in the cortex (14 with subclinical rejection, 32 with borderline change and 79 with only interstitial T-lymphocyte infiltration but no obvious pathological abnormalities according to Banff criteria) were enrolled. All cases were classified into two groups: regulatory phenotype (RP) group, which was dominated by FOXP3-positive T lymphocytes in surveillance biopsies, and cytotoxic phenotype (CP) group, which was dominated by Granzyme B-positive T lymphocytes. Results. The RP group includes 83.2% (104/125) cases, none of which developed acute rejection during nearly 5 years of follow-up. The CP group includes 16.8% (21/ 125) cases, all of which developed biopsy-proven acute rejection or clinical diagnostic acute rejection within 1 year after biopsy. Glomerular filtration rate and cumulative graft survival time were superior in the RP group than in the CP group (P < 0.001). Conclusion. Analyzing the immunophenotype of graftinfiltrating T cells in renal surveillance biopsies during early post-transplantation could predict acute rejection and survival.
Introduction
Advances in renal transplantation have resulted in great improvement of early allograft survival. The long-term survival of the transplants, however, was not improved simultaneously [1] , due to the chronic allograft dysfunction [2, 3] . Protocol biopsy performed on well-functioning grafts was first performed in the early 1990s and a series of studies were investigated [4] [5] [6] [7] [8] [9] [10] [11] . However, its invasive character limits its general use in routine practice; moreover, the clinical significance of lymphocyte infiltration in protocol biopsies is not clear; are they harmful or nonspecific? It is well known that functionally, significant renal allograft acute cellular rejection is usually diagnosed histologically based on specific patterns of tubulointerstitial lymphocyte infiltration in biopsies according to Banff criterion [12] [13] [14] [15] and early studies found that lymphocyte infiltration was also detected in surveillance biopsies [16] . A recent study showed that >85% of surveillance biopsies with stable allograft function had cellular infiltrates and >80% of cellular infiltrates were insufficient for the current Banff criteria to diagnose the rejection [17] . However, the impact of these unnoticed acute inflammatory infiltrates on graft prognosis was ambiguous. In our previous report [11] , borderline (BL) changes and subclinical rejection (SCR) detected in surveillance biopsy were associated with a high rejection rate and poor allograft survival, but there were still 70.6% of allografts in the SCR group and 78.4% in the BL group that kept stable renal function in the follow-up time. It indicated that the Banff diagnostic criterion has its limits in predicting allograft rejection in surveillance biopsy with stable renal function. Therefore, we introduced immunophenotype analysis of infiltrating T cells in surveillance biopsy early post-transplantation, and the results showed that it is a potential way to predict acute rejection and prognosis.
A series of studies have confirmed that Granzyme B, a serine protease released by cytotoxic T lymphocytes, is associated with acute renal cellular rejection [18] [19] [20] [21] and our previous study also confirmed this [22] . Recent studies have revealed that Forkhead Pwinged Helix 3 (FOXP3) is a specific functional biomarker of CD4+CD25+ regulatory T cells and plays an important role in the induction and maintenance of allograft tolerance [23] [24] [25] [26] . Clinical study demonstrated that non-invasive measurement of urinary FOXP3 messenger RNA could improve the prediction of outcome of acute renal rejection [27] . The studies mentioned above show that Granzyme B and FOXP3 reflect the immune state in renal biopsies, respectively, especially in the development of acute rejection, their expressions are significantly different from stable situation. We therefore postulated that the expression of Granzyme Bpositive and FOXP3-positive T lymphocytes in surveillance renal biopsies with stable renal function could predict acute rejection during follow-up.
Materials and methods

Patients
Two hundred and forty-two patients received a surveillance biopsy within 2 months (median time 40 days, range from 18 to 85 days) posttransplantation during August 2000 to July 2006 with stable allograft function from the Kidney Disease Centre, the First Affiliated Hospital, Zhejiang University, China. The study was approved by the Ethics Committee of the hospital. Fifty-eight tissue blocks were exhausted or had insufficient tissue for immunohistochemistry analysis, 14 cases were excluded for previous acute rejection before surveillance biopsy. Among the 170 biopsies, 45 (26.5%) had no T-lymphocytes infiltration; 125 (73.5%) non-exhausted tissue blocks with interstitial T-lymphocyte infiltration between non-atrophic tubules in the cortex were selected. One hundred and twenty-five biopsies with interstitial T-lymphocyte infiltration had different pathological diagnosis according to Banff criteria: 14 in SCR, 32 in BL change and 79 in only inflammatory cell infiltrations but no obvious pathological abnormalities (normal). Patients with acute tubular necrosis and urinary infection were excluded. Patients in the SCR group received anti-rejection treatment of methylprednisolone 200 mg intravenously for 3 days continuously.
Biopsy-proven acute rejection (BPAR) was defined as a rise in the serum creatinine at least 25% over the BL not explained by complications other than rejection such as urinary tract obstruction and proven by biopsy according to the Banff 2005 criteria [13, 14] . Clinical diagnostic acute rejection (CDAR) was defined as a rise in the serum creatinine at least 25% over the BL not explained by complications other than rejection such as urinary tract obstruction and vascular compromise, serum creatinine fell to normal level after anti-rejection treatment, but a biopsy was not taken.
Biopsies
Biopsies were performed under ultrasound guidance, processed for routine light microscopy and stained with hematoxylin-eosin (H&E), periodic acid-Schiff, Masson's trichrome and silver-methenamine. Pathological diagnosis was conducted by one pathologist with 20 years of experience according to the Banff criteria [13, 14] . All biopsies were adequate by Banff criteria and all had at least one interlobular artery. Only biopsies containing interstitial T-lymphocyte infiltration were considered.
Immunohistochemistry
Immunohistochemistry was performed on formalin-fixed tissue embedded in paraffin. After dewaxing in xylol, endogenous peroxidase activity was blocked with 0.03% H 2 O 2 ; antigen retrieval was performed using 0.1 M citrate buffer pH 6.0 under pressure; non-specific reactivity was blocked with horse normal; slides were then incubated with monoclonal primary antibodies overnight at 4°C temperature, FOXP3 (Abcam; clone 236A/E7) diluted 1:200 was used as a functional marker for regulatory T cell; Granzyme B (Chemicon; clone GrB-7) diluted 1:200 was used as a functional marker for cytotoxic T cell. CD3 was used as a marker of total T cell (Dako; polyclonal), CD4 was used as a marker of CD4-positive T cell (Maixin; clone 4B12), CD8 was used as a marker of CD8-positive T cell (Dako; clone 144B), CD20 was used as a marker of B cell (Dako; clone L26) and CD68 was used as a marker of macrophage cell (Dako; clone KP1). Slides were washed with phosphate-buffered saline between steps. Sections were counterstained in Harris's hematoxylin for 2 min, rinsed in running tap water for 5 min, dehydrated and mounted with Hystomount. Sections were examined by microscope and compared to the original H&E sections. The number of positive-stained cells for each cell marker was counted in 10 consecutive high power (× 400) fields in all biopsies and expressed as the number of positive-stained cells per square millimeter. Quantitation of positive cell number and the ratio of FOXP3-positive T cells to Granzyme B-positive T cells were recorded simultaneously. An investigator blinded to the identity and outcome of the patients analyzed the slides. Allografts where infiltrates were dominated by FOXP3-positive T lymphocytes fell under the regulatory phenotype (RP) group, allografts where infiltrates were dominated by Granzyme B-positive T lymphocytes fell under the cytotoxic phenotype (CP) group.
Clinical variables
The following clinical variables were recorded for each patient at the time of surgery: sex, age, primary disease, cold ischemic time, hot ischemic time, Panel Reactive Antibody (PRA) level, Human Leukocyte Antigen (HLA) mismatches, immunosuppressant regimen, time from transplantation to biopsy and the simplified equation of Modification of Diet in Renal Disease calculated estimated glomerular filtration rate (eGFR) on biopsy day were recorded as baseline data; immunosuppressant regimen and eGFR at different time points post-transplantation and episodes of acute rejection during follow-up were also recorded. The end of follow-up was 31 March 2008. The clinical outcome during the follow-up time was recorded from our electronic database.
Statistics
Results are expressed as the mean ± SD. Chi-square test, Fisher exact test, unpaired t-tests and Mann-Whitney U-tests were used for comparisons between groups. The binary logistic regression analysis was used to explore the relations between the infiltrating T-cell types and the allograft function and outcome. The Kaplan-Meier method was used to calculate graft and patient survival analyzed by log-rank test. All P-values were two-tailed and a P-value <0.05 was considered significant.
Results
Immunophenotype of interstitial infiltrating T cells
All biopsies with infiltrating T lymphocytes were partly FOXP3 positive and partly Granzyme B positive ( Figure 1 ). Accordingly, we named ratio of FOXP3-positive T cells to Granzyme B-positive T cells more than one as 'RP', named FOXP3-positive T cells to Granzyme Bpositive T cells less than one as 'CP'. The absolute value of the FOXP3/Granzyme B ratio is distributed non-normally and the details are listed in Table 1 . Different types of cell infiltrates were not significantly different between two groups (Table 2) . Surveillance biopsies [83.2% (104/125)] presented with RP, the infiltrating T lymphocytes were dominated by FOXP3-positive T lymphocytes; 16.8% (21/125) surveillance biopsies presented with CP, the infiltrating T lymphocytes were dominated by Granzyme B-positive T lymphocytes. According to the Banff histopathological criterion, all 125 cases were diagnosed as SCR, BL change and normal. The Banff grades in patients with SCR were as follows: RP group-10/11 Banff IA and 1/ 11 Banff IIA; CP group-1/3 Banff IA and 2/3 Banff IIA. Each pathological classification subgroup includes both RP and CP (Figure 2 ). Statistical analysis found no significant difference with the distribution of infiltrating Tcell immunophenotype among pathological classification subgroups (P = 0.772).
We tested peritubular C4d deposition in all 125 biopsies and found negative staining. We did not find evidence of chronic rejection, but we did find focal (<25%) tubular atrophy and interstitial fibrosis in three biopsies when acute rejection developed during the follow-up.
Baseline characteristics of patients presented with different immunophenotype
Demographic details are shown in Table 3 . There were more male patients in the CP group, but no significant differences between the two groups in age, primary renal diseases, cold ischemia time, warm ischemia time, PRA level, HLA mismatches, immunosuppression, time from transplantation to biopsy and eGFR on biopsy day.
Clinical outcomes during follow-up time
Clinical outcomes of the patients who received surveillance biopsies were recorded during the follow-up time, except for eight cases who died within 1 year post-transplantation (three cases in the CP group and five cases in the RP group). In the CP group, two patients died of severe pulmonary infection within 5 months post-transplantation with well-functioning renal allografts and one patient died of irreversible allograft rejection 10 months post-transplantation. In the RP group, one patient died of ruptured aneurysms 3 months post-transplantation, three patients died of severe pulmonary infection within 5 months post-transplantation and one patient died of hepatic failure 12 months post-transplantation with wellfunctioning renal allografts.
The clinical course of each patient during the follow-up was analyzed. No allograft in the RP group from surveillance biopsies developed acute rejection during nearly 5 years follow-up; all allografts in the CP group developed acute rejection within 1 year after biopsy, including 11 cases of BPAR and 10 cases of CDAR, the median interval time between surveillance biopsy and acute rejection was 3 months (Table 4 ). The absolute value of the FOXP3/Granzyme B ratio in the BPAR and CDAR group are listed, and the binary logistic regression analysis revealed that the absolute value of ratio was not correlated with the development of acute rejection and the type of acute rejection (Table 5) . We made the logistic regression of the ratio and graft survival, and found that a higher ratio correlated with superior graft function (P < 0.001).
In order to explore the impact of immunosuppressants on acute rejection episodes, we recorded the immunosuppressive regimen at different time points post-transplantation ( Figure 3 ) and found that prednisone dosage of CP group in 9-12 months post-transplantation was significantly higher than RP group, but the dosage and concentration of calcineurin inhibitors (CNIs) of the two groups were similar.
Patients in CP group had significantly lower eGFR after 1 year post-transplantation and the difference maintained during the follow-up compared with RP group (Figure 4) . Compared to the day on biopsy, we also observed an increase of eGFR in the RP group and a decline of eGFR in the CP group after 1 year post-transplantation. However, the eGFR level did not demonstrate a significant difference among different time points post-transplantation within the RP or CP groups. Cumulative graft survival time of patients (death with functioning graft was censored) in the CP group was significantly less than that in the RP group (P < 0.001) ( Figure 5 ).
Discussion
Until now, pathological diagnosis was the golden criteria in evaluating the function of renal allograft irrespective of its limitations. Infiltrating mononuclear cells, especially T lymphocytes, play a major role in the Banff criterion. However, the phenotype of infiltrating T lymphocytes is not considered. In this study, we analyzed the immunophenotype of Tlymphocyte infiltration in surveillance renal allograft biopsies and explored the immune state evaluation value of FOXP3 (functional marker of regulatory T cells) and Granzyme B (functional marker of cytotoxic T cells) in combination with clinical data. Our results showed that the ratio of FOXP3-positive T cells to Granzyme B-positive T cells in renal allograft was a sensitive and specific marker to discriminate between 'RP' and 'CP'. Clinical data revealed that from 125 surveillance biopsies, no allograft in the RP group developed acute rejection during the follow-up (median time 56 months); all allografts in the CP group developed acute rejection within 1 year after biopsy. In the 21 rejection cases, 11 were BPAR and another 10 were CDAR. We also observed that the dosage and concentration of CNIs were similar between the two groups, otherwise the prednisone dosage of the CP group in 9-12 months post-transplantation was significantly higher than that of the RP group. Because the median time between biopsy and acute rejection was 5 months post-transplantation (range from 3 to 12 months), the higher dosage of prednisone in the CP group 9-12 months post-transplantation may be the result of dosage adjustment after acute rejection occurred early post-transplantation in this group. Patients in the RP group had superior eGFR post-transplantation and cumulative graft survival compared with the CP group (death with functioning graft was censored, P < 0.001). It indicated that the higher acute rejection rate in the CP group was not because of insufficient immunosuppressants. We also supposed that CP in surveillance biopsies may have had an impact on renal function and graft survival. The improvement of eGFR level in RP group may be due to the benefits of low-dose usage of CNIs in our centers. It is validated in a retrospective study conducted by our center, in which gradual improvement of eGFR level in 163 patients who received low-dose usage of CNIs was seen at 1 month and maintained over the 60 months of the study (data have not been published).
There were no additional later biopsies for 104 patients in the RP group because the majority of patients could not comply with the second biopsy in the light of steady allograft function, but they all received strict follow-up. Current perspectives on the therapeutic regimen for patients whose allograft presented with abnormal histopathological presentations in surveillance biopsies are in debate. Some researchers hold affirmative attitudes [6, 9] , while others do not [10] . A recent controlled clinical study concluded that asymptomatic infiltrates in 6-month surveillance biopsies may not be deleterious, but further analysis of cell infiltrates was very important [28] . Our previous study revealed that BL changes and SCR detected in surveillance biopsy were associated with a high rejection rate and poor allograft survival [11] , but there were still 70.6% allografts in the SCR group and 78.4% in the BL group that kept stable renal function in the follow-up period. On the other hand, 7.5% in normal group developed acute rejection. It indicated that the Banff diagnostic criterion has its limitations in protocol biopsies with stable renal function, further immunophenotype analysis of infiltrating T lymphocytes may have clinical significance. In the present study, immunophenotype analysis of infiltrating T lymphocytes revealed that all patients developed acute rejection post-biopsy presented with CP.
Previous studies associated with protocol biopsies revealed that the 3 months after renal transplantation was the peak time for lymphocytes infiltration [4] . Current study indicated that single surveillance biopsies early post-transplantation could predict development of acute rejection and prognosis by the means of analyzing immunophenotype of infiltrating T lymphocytes. We supposed that for ∼73% of patients with interstitial infiltrates, single surveillance biopsy could replace protocol biopsies post-transplantation. Immunophenotype of infiltrating T cells could guide the regulation of immunosuppressants. For patients presented with CP, augmentation of immunosuppressants may be beneficial for clinical prognosis, and for patients with RP, decreased immunosuppressants may contribute to decreased side effects, and larger sample and prospective randomized control study need to be further conducted to support it. There is one hypothesis that the renal allograft immune response includes both the activation of graft-destructive effector cells and graft-protective regulatory cells, the balance between these two cell types decides the prognosis of allograft [29] . Here are two possible mechanisms to illustrate the phenomena: one is that the regulatory T cells prevent the emergence of effector cells and another is that the regulatory T cells exert damage control against effector cells [30] . Our results support the latter theory, that is, graft-destructive effector cells as well as graft-protective regulatory cells were both present in the allograft from surveillance biopsies, allografts dominated by FOXP3-positive T lymphocytes presented with RP and stable renal function, while allografts dominated by Granzyme B-positive T lymphocytes presented with CP and developed acute rejection soon.
In the present study, immunophenotype of infiltrating T cells and nearly 5 years follow-up data revealed that single surveillance biopsy could replace protocol biopsies post-transplantation; however, there were 45 (26.5%) cases with no T-lymphocyte infiltrations among 170 surveillance biopsies. We analyzed the clinical data of this population during the follow-up (median time 54 months) and noticed that the baseline characteristics and immunosuppressants were similar compared with RP and CP groups (data not shown), but there were still six (13.3%) patients who developed acute rejection (median time between biopsy and acute rejection 17 months, range from 2 to 36 months), and the interval time between biopsy and acute rejection was longer compared with that of the CP group (median time 3 months, range from 1 to 10 months). On the one hand, no infiltrates detected may be the limitations of biopsy; on the other hand, delayed acute rejection may be associated with delayed T-lymphocyte infiltrates, additional biopsies 3-6 months later may detect infiltrates instead of protocol biopsies, further analysis of the immunophenotype of these infiltrates could predict acute rejection and prognosis. In this study, 11 cases of BPAR were acute cellular rejection; the results could not be extended if the acute rejection was antibody mediated.
Bestard et al. [31] evaluated 37 cases of SCR in 6-month protocol biopsies and showed that the presence of FOXP3-positive regulatory T cells could predict better graft function 2 and 3 years after transplantation and the FOXP3+ Treg/CD3+ T-cell ratio positively correlated with graft function at 2 years after transplantation, suggesting that an increasing proportion of Treg within the global T-cell infiltrate may facilitate renal engraftment. Their results emphasized the importance of FOXP3+ Treg in better renal allograft survival, it was the same as ours, but our study placed emphasis on the ratio of FOXP3-positive T cells to Granzyme B-positive T cells, which could reflect the balance of two active T-cell populations. In addition, our study also included biopsies with normal pathological presentation by Banff criteria. Taflin et al. [32] showed that Treg recruitment at the acute phase of the allogenic response, where they could act to diminish the interstitial inflammation and its associated lesions, but the proportion of CD4+FOXP3+ T cells within protocol biopsies did not correlate with graft outcome, we supposed that the time of protocol biopsy was not similar to ours, the immune state of the allografts was different within 3 months post-transplantation and 1 year posttransplantation.
In conclusion, FOXP3 and Granzyme B are sensitive and specific markers in evaluating immunophenotype of infiltrating T lymphocytes. FOXP3 represents RP and Granzyme B represents CP. Patients with CP had higher risk of acute rejection, inferior renal function and worse graft survival. A larger sample and multicenter studies are needed to confirm the present conclusion in the future.
